Like for many multifactorial and chronic diseases,2 it is critical to offer both pharmacological and non-pharmacological options to your employees with obesity, as one specific strategy will not address the needs of everyone in your organization.3
TAKING ACTION
Like for many multifactorial and chronic diseases,2 it is critical to offer both pharmacological and non-pharmacological options to your employees with obesity, as one specific strategy will not address the needs of everyone in your organization.3
Download The Weigh Forward Module 2 to explore how comprehensive weight management impacts your organization, through factors such as obesity prevalence, associated comorbidities among employees, and associated healthcare costs.
Download The Weigh Forward Module 3 for guidance on adding an addendum or rider for AOMs, ensuring coverage, and accessing sample communications to inform healthcare providers about employee AOM coverage.
An informational program for transportation employers and employees to help educate about commercial driver’s license (CDL) driver health, productivity, and safety. Please contact an Account Manager for more information regarding this program.
References: 1. Nobel J, Pickering L, Sasser E. Tipping the scales on weight control: new strategies for employers. Northeast Business Group on Health. Published August 2016. Accessed May 18, 2023. https://nebgh.org/wp-content/uploads/2016/08/NEBGH_Tipping-the-Scales-2016.pdf 2. Mechanick JI, Garber AJ, Handelsman Y, Garvey WT. American Association of Clinical Endocrinologists’ position statement on obesity and obesity medicine. Endocr Pract. 2012;18(5):642-648. 3. Wadden TA, Berkowitz Rl, Womble LG, et al. Randomized trial of lifestyle modification and pharmacotherapy for obesity. N Engl J Med. 2005;353(20):2111-2120. 4. Garvey WT, Mechanick JI, Brett EM, et al. Reviewers of the AACE/ACE Obesity Clinical Practice Guidelines. American Association of Clinical Endocrinologists and American College of Endocrinology comprehensive clinical practice guidelines for medical care of patients with obesity. Endocr Pract. 2016;22(suppl 3):1-203.